HESSEL PHARMA ApS: Financial statements 2014
CVR: 32560903
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
HESSEL PHARMA ApS (CVR 32560903) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -707,859 and a net result of DKK -756,749 compared with DKK -627,841 the year before. Equity in the 2014 report amounted to DKK -774,070.
- Gross Profit
- DKK -707,859
- Profit/Loss
- DKK -756,749
- Equity
- DKK -774,070
- Total Assets
- DKK 352,532
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -708K | -757K | -774K | - |
| 2013 | - | -456K | -628K | -17K | - |
| 2012 | - | 1.2M | 133K | 611K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
HESSEL PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -455,962, and the net result was DKK -627,841.
As of January 2, 2014, PIASTER REVISORERNE, GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of HESSEL PHARMA ApS.
As of January 2, 2014, PIASTER, LØFGREEN & PARTNERE, STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of HESSEL PHARMA ApS.
About HESSEL PHARMA ApS
HESSEL PHARMA ApS was a Danish company of the type Anpartsselskab based in Stenløse, founded in 2009. The company has been dissolved on 7 December 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2013). In 2019, the company reported a gross profit of DKK 3,305,350 and a net result of DKK 2,575,472 compared with DKK 30,406 the year before. Equity in the 2019 report amounted to DKK 635,471.